07/17/2026
UC San Diego’s Gene Therapy Initiative at UC San Diego, California Life Sciences (CLS), and the California Institute for Regenerative Medicine (CIRM) bring you to a two-day deep dive into the cell and gene therapy ecosystem. See attached flyer.
This symposium brings together the brightest minds in the field to bridge the gap between laboratory discovery and commercial scale.
Event Schedule:
Day 1: Sept 16 | Discovery & Translation (Hosted by UC San Diego GTI) Focusing on the frontier of therapy development, featuring keynote Kiran Musunuru (UPENN/TIME 100) and leadership from UCSD, Regeneron, Editas Medicine, N-Lorem, and Siren Biotechnology. Discussions will center on bold strategies for ex vivo/in vivo therapies and safety models.
Day 2: Sept 17 | Commercialization & Scale (Hosted by CLS & CIRM) A focused look at the business of biotech, featuring expert panels on manufacturing, funding, policy, and the path to patient delivery.
Location: Conrad Prebys Auditorium, Salk Institute, La Jolla, CA
Why Attend?
Present Your Research: We are currently accepting abstracts for our Sept. 16 poster sessions. This is a premier opportunity to showcase your work to industry leaders. Link: Submit your abstract by August 7th https://buff.ly/pNi8WNl
High-Value Networking: Connect with the researchers, investors, and executives shaping regenerative medicine in Southern California.
End-to-End Insight: Gain a comprehensive perspective from the initial lab bench to market launch.
Registration: Tickets sell out quickly. We offer discounted pricing for those attending both days.
Register Now https://buff.ly/EqhY34h
View Final GTI Program https://buff.ly/faxZw5y
Full CLS/CIRM Program coming soon https://buff.ly/gSWhbhk
Contact: [email protected]
